Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Dr Robert Beagrie, a postdoc in the research group of Prof Doug Higgs at the MRC Molecular Haematology Unit (Radcliffe Department of Medicine)! Robert was a awarded a prestigious Sir Henry Wellcome Postdoctoral Fellowship, a four-year award that offers recently qualified postdoctoral researchers the opportunity to start independent research careers.

Headshot of Robert Beagrie

Robert will be working with Prof Doug Higgs and Assoc. Prof. Merav Socolovsky (University of Massachusetts Medical School) to study gene regulation in early red blood cell progenitors. Rob’s project will investigate how DNA regulatory elements called enhancers drive the activation of thousands of genes as these cells enter terminal differentiation, during a fascinating transition point that is tightly synchronised with the cell cycle. Before moving to the MRC WIMM Robert did a PhD in the lab of Prof Ana Pombo at the Max Delbrück Center for Molecular Medicine in Berlin, where he developed a new method for measuring how DNA folds inside cells.

Similar stories

Wellcome Trust funding success for Jim Hughes and James Davies

£3.6 million in funding awarded by the Wellcome Trust to combine cutting-edge 3D genome technologies with machine learning approaches to decipher the role of the non-coding genome in disease.

Study of T-cell receptor activation leads to surprising discovery

A study from Davis Group is the first to describe the structure of the T-cell receptor when bound to an activating ligand. The findings shed light on an important trigger in the immune system, and suggest a completely new process by which cell receptors can be activated.

Biotech spinout MiroBio acquired by Gilead Sciences for ~£332m

Co-founded by Prof. Simon Davis, MiroBio focuses on developing therapeutics for inflammatory diseases.

Seven research groups secure LEAF Sustainability Awards

The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.

Ewa Gogola receives Wellcome Early Career Award

Dr Ewa Gogola from the Patel Group in the MRC Molecular Haematology Unit has been awarded funding by the Wellcome Trust for the project ‘DNA damage-induced hepatocyte polyploidisation- how it happens and what are its consequences?’